ReShape Lifesciences Inc. , a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.
Reshape Lifesciences stock last closed at $0.17, down 4.49% from the previous day, and has decreased 92.48% in one year. It has underperformed other stocks in the Medical Devices industry by 0.77 percentage points. Reshape Lifesciences stock is currently +20.57% from its 52-week low of $0.14, and -93.92% from its 52-week high of $2.80.
As of Apr 26, 2024, there are 23.46M shares of RSLS outstanding. The market value of RSLS is $3.99M. In the past 24 hours, 317,860 RSLS shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy RSLS stock.
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro today.
Open eToro AccountNow that you've chosen the right brokerage, the next step is to fill out some personal details so you are able to buy RSLS today.
Now that you have finished signing up on the best stock market app, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help depositing funds into your new brokerage account.
Once you have identified the best place to buy Reshape Lifesciences stock, it's absolutely critical to research their stock before you invest, so you can understand the risk as well as the upside.
WallStreetZen was built to help average investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on RSLS's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge RSLS's intrinsic value.
Using relative valuations methods:
You can do more valuation research on RSLS's stock here.
Last year, RSLS revenue was $8.68M. Over the past five year, RSLS's revenue has grown by -0.95% per year. This was slower than the Medical Devices industry average of 13.26%.
Find out more about RSLS's earnings and revenue performance here.
In the last year, executives and large shareholders at RSLS have bought more shares than they have sold.
Thomas Stankovich, Chief Financial Officer of RSLS, was the latest RSLS insider to sell. They sold $35.37 worth of RSLS shares on Oct 25, 2023.
Research more about who owns RSLS stock here.
No, Reshape Lifesciences doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
You have two main order types:
Hit the Open button and your broker will place your order.
If you require more help with investing in stocks on eToro, watch the how to video below:
Now that you own some shares in RSLS, you'll want to stay up-to-date on your stock purchase.
Add RSLS to a watchlist to see the latest developments about your RSLS stock.
To summarize, here are the 6 steps to buy stock in Reshape Lifesciences:
If you need a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest news on your investment in Reshape Lifesciences, create a watchlist today.